Equity Overview
Price & Market Data
Price: $0.397
Daily Change: -$0.0368 / 9.26%
Daily Range: $0.396 - $0.486
Market Cap: $6,512,291
Daily Volume: 1,932,393
Performance Metrics
1 Week: -12.93%
1 Month: 29.81%
3 Months: -40.39%
6 Months: -47.07%
1 Year: -59.13%
YTD: -59.13%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.